Literature DB >> 29066584

Predicting 30-Day All-Cause Readmission Risk for Subjects Admitted With Pneumonia at the Point of Care.

Umur Hatipoğlu1, Brian J Wells2, Kevin Chagin3, Dhruv Joshi4, Alex Milinovich3, Michael B Rothberg5.   

Abstract

BACKGROUND: The pneumonia 30-d readmission rate has been endorsed by the National Quality Forum as a quality metric. Hospital readmissions can potentially be lowered by improving in-hospital care, transitions of care, and post-discharge disease management programs. The purpose of this study was to create an accurate prediction model for determining the risk of 30-d readmission at the point of discharge.
METHODS: The model was created using a data set of 1,295 hospitalizations at the Cleveland Clinic Main Campus with pneumonia over 3 y. Candidate variables were limited to structured variables available in the electronic health record. The final model was compared with the Centers for Medicare and Medicaid Services (CMS) model among subjects 65 y of age and older (n = 628) and was externally validated.
RESULTS: Three hundred thirty subjects (25%) were readmitted within 30 d. The final model contained 13 variables and had a bias-corrected C statistic of 0.74 (95% CI 0.71-0.77). Number of admissions in the prior 6 months, opioid prescription, serum albumin during the first 24 h, international normalized ratio and blood urea nitrogen during the last 24 h were the predictor variables with the greatest weight in the model. In terms of discriminative performance, the Cleveland Clinic model outperformed the CMS model on the validation cohort (C statistic 0.69 vs 0.60, P = .042).
CONCLUSIONS: The proposed risk prediction model performed better than the CMS model. Accurate readmission risk prediction at the point of discharge is feasible and can potentially be used to focus post-acute care interventions in a high-risk group of patients.
Copyright © 2018 by Daedalus Enterprises.

Entities:  

Keywords:  health-care utilization; pneumonia readmission; prediction model

Mesh:

Year:  2017        PMID: 29066584     DOI: 10.4187/respcare.05719

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  9 in total

1.  CURB-65 plus hypoalbuminemia: a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia.

Authors:  Alessandra Oliva; Cristian Borrazzo; Maria Teresa Mascellino; Ambrogio Curtolo; Dania Al Ismail; Francesca Cancelli; Gioacchino Galardo; Tommaso Bucci; Giancarlo Ceccarelli; Gabriella d'Ettorre; Francesco Pugliese; Claudio M Mastroianni; Mario Venditti
Journal:  Infez Med       Date:  2021-09-10

2.  A continuous-time Markov model for estimating readmission risk for hospital inpatients.

Authors:  Xu Zhang; Sean Barnes; Bruce Golden; Paul Smith
Journal:  J Appl Stat       Date:  2020-01-03       Impact factor: 1.416

3.  Development of a risk prediction model of potentially avoidable readmission for patients hospitalised with community-acquired pneumonia: study protocol and population.

Authors:  Anne-Laure Mounayar; Patrice Francois; Patricia Pavese; Elodie Sellier; Jacques Gaillat; Boubou Camara; Bruno Degano; Mylène Maillet; Magali Bouisse; Xavier Courtois; José Labarère; Arnaud Seigneurin
Journal:  BMJ Open       Date:  2020-11-11       Impact factor: 2.692

4.  Incidence of Avoidable 30-Day Readmissions Following Hospitalization for Community-Acquired Pneumonia in France.

Authors:  Bastien Boussat; Fabiana Cazzorla; Marion Le Marechal; Patricia Pavese; Anne-Laure Mounayar; Elodie Sellier; Jacques Gaillat; Boubou Camara; Bruno Degano; Mylène Maillet; Xavier Courtois; Magali Bouisse; Arnaud Seigneurin; Patrice François
Journal:  JAMA Netw Open       Date:  2022-04-01

5.  Leveraging Advanced Data Analytics to Predict the Risk of All-Cause Seven-Day Emergency Readmissions.

Authors:  Mohammed D Aldhoayan; Afnan M Khayat
Journal:  Cureus       Date:  2022-08-03

Review 6.  Predictive models for identifying risk of readmission after index hospitalization for hip arthroplasty: A systematic review.

Authors:  Satish M Mahajan; Amey Mahajan; Chantal Nguyen; Justin Bui; Bruce T Abbott; Thomas F Osborne
Journal:  J Orthop       Date:  2020-04-01

7.  Effect of albumin administration on outcomes in hypoalbuminemic patients hospitalized with community-acquired pneumonia (ALBUCAP): a prospective, randomized, phase III clinical controlled trial-a trial protocol.

Authors:  Alexander Rombauts; Gabriela Abelenda-Alonso; Antonella Francesca Simonetti; Guillermo Verdejo; Yolanda Meije; Lucia Ortega; Mercedes Clemente; Jordi Niubó; Yolanda Ruiz; Carlota Gudiol; Cristian Tebé; Sebastian Videla; Jordi Carratalà
Journal:  Trials       Date:  2020-08-20       Impact factor: 2.279

8.  Effects of fluid and drinking on pneumonia mortality in older adults: A systematic review and meta-analysis.

Authors:  Lee Hooper; Asmaa Abdelhamid; Sarah M Ajabnoor; Chizoba Esio-Bassey; Julii Brainard; Tracey J Brown; Diane Bunn; Eve Foster; Charlotte C Hammer; Sarah Hanson; Florence O Jimoh; Hassan Maimouni; Manraj Sandhu; Xia Wang; Lauren Winstanley; Jane L Cross; Ailsa A Welch; Karen Rees; Carl Philpott
Journal:  Clin Nutr ESPEN       Date:  2021-11-19

9.  Use of electronic medical records in development and validation of risk prediction models of hospital readmission: systematic review.

Authors:  Elham Mahmoudi; Neil Kamdar; Noa Kim; Gabriella Gonzales; Karandeep Singh; Akbar K Waljee
Journal:  BMJ       Date:  2020-04-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.